These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 2441050)

  • 21. [Evaluation of the effects of plafibride and lysine acetyl salicylate on the production of PGI2].
    Lasierra J; Díez MM; Fernández A; Viladés E; Gil M; Velázquez E
    Sangre (Barc); 1983; 28(6):687-95. PubMed ID: 6424250
    [No Abstract]   [Full Text] [Related]  

  • 22. Hypolipemic activity of plafibride.
    Bruseghini L; Vilageliu J; Bagaria A
    Arzneimittelforschung; 1981; 31(10a):1796-800. PubMed ID: 7198456
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hypocholesterolemic and antiaggregatory properties of 2-hydroxytetronic acid redox analogues an their relationship to clofibric acid.
    Witiak DT; Kokrady SS; Patel ST; Huzoor Akbar H; Feller DR; Newmann HA
    J Med Chem; 1982 Jan; 25(1):90-3. PubMed ID: 7086828
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of the gating of CIC-1 by S-(-) 2-(4-chlorophenoxy) propionic acid.
    Aromataris EC; Astill DS; Rychkov GY; Bryant SH; Bretag AH; Roberts ML
    Br J Pharmacol; 1999 Mar; 126(6):1375-82. PubMed ID: 10217531
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Synthesis and pharmacological evaluation of N'-morpholinomethylurea derivatives with platelet antiaggregant activity.
    Ribalta JM; Artús JJ; Salvador L; Roma E; Vilageliu J; Freixes J; Bruseghini L
    Arzneimittelforschung; 1981; 31(10a):1782-6. PubMed ID: 6797442
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Irreversible inhibition of hepatic glutathione S-transferase by ciprofibrate, a peroxisome proliferator.
    Awasthi YC; Singh SV; Goel SK; Reddy JK
    Biochem Biophys Res Commun; 1984 Sep; 123(3):1012-8. PubMed ID: 6487318
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Branched chain amino acid oxidation in cultured rat skeletal muscle cells. Selective inhibition by clofibric acid.
    Pardridge WM; Casanello-Ertl D; Duducgian-Vartavarian L
    J Clin Invest; 1980 Jul; 66(1):88-93. PubMed ID: 7400311
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of phenylbutazone, tolbutamide, and clofibric acid on binding of racemic warfarin and its enantiomers to human serum albumin.
    Veronich K; White G; Kapoor A
    J Pharm Sci; 1979 Dec; 68(12):1515-8. PubMed ID: 529041
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacologic treatment of hyperlipidemia reduces glomerular injury in rat 5/6 nephrectomy model of chronic renal failure.
    Kasiske BL; O'Donnell MP; Garvis WJ; Keane WF
    Circ Res; 1988 Feb; 62(2):367-74. PubMed ID: 3338121
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential eudismic ratios in the antagonism of human platelet function by phenoxy- and thiophenoxyacetic acids.
    Romstedt KJ; Lei LP; Feller DR; Witiak DT; Loiodice F; Tortorella V
    Farmaco; 1996 Feb; 51(2):107-14. PubMed ID: 8857205
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of long-term clofibric acid treatment on serum and tissue lipid and cholesterol levels in obese Zucker rats.
    Cleary MP; Kasiske B; O'Donnell MP; Keane WF
    Atherosclerosis; 1987 Jul; 66(1-2):107-12. PubMed ID: 3632741
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Synthesis and antiplatelet activity of thioaryloxyacids analogues of clofibric acid.
    Ammazzalorso A; Amoroso R; Baraldi M; Bettoni G; Braghiroli D; De Filippis B; Giampietro L; Tricca ML; Vezzalini F
    Eur J Med Chem; 2005 Sep; 40(9):918-21. PubMed ID: 15950326
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bioavailability of plafibride in healthy volunteers.
    Santaniello E; Conti F; Vilageliu J; Bruseghini L
    Arzneimittelforschung; 1981; 31(10a):1850-2. PubMed ID: 7198464
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of three hypolipidemic drugs on catalase activity and peroxisomal and mitochondrial palmitate oxidation in rat cardiac and skeletal muscle.
    MacDonald RS; Swan PB
    Biochim Biophys Acta; 1986 Feb; 880(2-3):153-60. PubMed ID: 3942787
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of etofibrate on platelet function: in vitro studies in human plasma.
    Ortega MP; Sunkel C; Armijo M; Priego JG
    Thromb Res; 1980 Aug; 19(3):409-16. PubMed ID: 7001672
    [No Abstract]   [Full Text] [Related]  

  • 36. Plafibride: clinical trial of a new platelet antiaggregating agent.
    Olivella J; Vicens B
    Arzneimittelforschung; 1981; 31(10a):1856-8. PubMed ID: 7032532
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Hypolipemic effect of amino acid derivatives of clofibric acid].
    Wójcicki J; Samochowiec L; Gawrońska-Szklarz B; Kwapiszewski W; Borkowski L
    Acta Pol Pharm; 1985; 42(3):305-8. PubMed ID: 4096253
    [No Abstract]   [Full Text] [Related]  

  • 38. Effects of long-term administration of clofibric acid on peroxisomal beta-oxidation, fatty acid-binding protein and cytosolic long-chain acyl-CoA hydrolases in rat liver.
    Kawashima Y; Katoh H; Watanuki H; Takegishi M; Kozuka H
    Biochem Pharmacol; 1985 Feb; 34(3):325-9. PubMed ID: 2857564
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased activity of stearoyl-CoA desaturation in liver from rat fed clofibric acid.
    Kawashima Y; Kozuka H
    Biochim Biophys Acta; 1982 Dec; 713(3):622-8. PubMed ID: 6129897
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 20,25-Diazacholesterol, clofibric acid and 2,4-dichlorophenoxyacetic acid--all inducers of myotonia--perturb the post-lanosterol sector of sterol biosynthesis in cultured chick embryo fibroblasts.
    Emmons GT; Rosenblum ER; Malloy JM; McManus IR; Campbell IM
    Biochem Biophys Res Commun; 1980 Sep; 96(1):34-8. PubMed ID: 7437038
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.